Results 111 to 120 of about 5,495 (171)

The Regeneration of D,1-Fenfluramine-Destroyed Serotonergic Nerve-Terminals

, 1993
The regeneration of serotonergic nerve terminals subsequent to their destruction by high-dose fenfluramine administration was examined. Treating rats with fenfluramine (80 mg/kg over 2 days) destroyed 80% of serotonergic nerve terminals, indicated by ...
Westphalen, RI, Dodd, PR
core  

EmergencyTreatmentandNursingCareforthePatientswithFenfluraminePoisoningBecauseofMisuse（ReportofTwoCases）

Huli yanjiu, 1996
２例误服芬氟拉明中毒患者的急救与护理ＥｍｅｒｇｅｎｃｙＴｒｅａｔｍｅｎｔａｎｄＮｕｒｓｉｎｇＣａｒｅｆｏｒｔｈｅＰａｔｉｅｎｔｓｗｉｔｈＦｅｎｆｌｕｒａｍｉｎｅＰｏｉｓｏｎｉｎｇＢｅｃａｕｓｅｏｆＭｉｓｕｓｅ（ＲｅｐｏｒｔｏｆＴｗｏＣａｓｅｓ）０３７...
马丽萍, 张民成, 林秀英, 陈颖清   +3 more
doaj  

Reversible Pulmonary Arterial Hypertension Due to Fenfluramine in a Young Child: A Case Report. [PDF]

Cureus
Ndukwe U, Parkey A, Samanta D, Masri A, Willis E.   +4 more
europepmc   +1 more source

Effects of fenfluramine and sigma-1-dependent pharmacological and genetic modulation in a mouse kindling model. [PDF]

Epilepsia
von Rüden EL, Buchecker V, Wagner A, Stocker VM, Zvejniece L, Potschka H.   +5 more
europepmc   +1 more source

Practical Recommendations for Cardiology Follow-Up in Patients Treated with Fenfluramine Based on Expert Opinion and Clinical Experience. [PDF]

Neurol Ther
Gil-Nagel A, de la Isla LP, Pascual ES, Balbacid Domingo EJ, García Peñas JJ.   +4 more
europepmc   +1 more source

Fenfluramine Attenuates Retinal Microglial Activation but Does Not Rescue Structural and Vascular Deficits in a Rat Model of Dravet Syndrome. [PDF]

Int J Mol Sci
Zhang Y, Qian W, Li M, Zou YY, Lu Z, Huang Z, Naumann RK, Wang H.   +7 more
europepmc   +1 more source

Reversible severe mitral regurgitation during immunotherapy in a structurally vulnerable valve: a case report. [PDF]

Eur Heart J Case Rep
Singh S, Majmudar U, Poornima I, Radhakrishnan A.   +3 more
europepmc   +1 more source

Phentermine-Induced Dilated Cardiomyopathy: A Case Report and Review of Literature. [PDF]

Cureus
Chamay S, Chekhava D, Dandamudi M, Giorgi J, Shaik F.   +4 more
europepmc   +1 more source

Disrupted inhibitory interneuron development in SCN1A Dravet syndrome revealed by patient-derived subpallial organoids. [PDF]

Epilepsia
Mattei C, Mao M, Byars S, Syazwan EM, Oliva M, Karle TJ, Richards K, Scheffer IE, Petrou S, Maljevic S.   +9 more
europepmc   +1 more source

Ameliorating Seizures in Dravet Syndrome: A Review of Newly Approved and Investigational Drugs, RNA and Gene-Based Therapies. [PDF]

CNS Drugs
Balestrini S, Scheffer IE.
europepmc   +1 more source